Skip to Content

TEVA 5046 (Dexmethylphenidate Hydrochloride Extended-Release 35 mg)

Pill with imprint TEVA 5046 is Blue & White, Capsule-shape and has been identified as Dexmethylphenidate Hydrochloride Extended-Release 35 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Dexmethylphenidate is used in the treatment of adhd and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Dexmethylphenidate 35 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for TEVA 5046

Dexmethylphenidate hydrochloride extended-release 35 mg TEVA 5046

Dexmethylphenidate Hydrochloride Extended-Release

Imprint
TEVA 5046
Strength
35 mg
Color
Blue & White
Size
23.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
CNS stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)
00093-5046
Inactive Ingredients
ammonio methacrylate copolymer type B, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Blue No. 2, indigotindisulfonate sodium, FD&C Red No. 40, hypromellose 2208 (3 mPa.s), ferrosoferric oxide, methacrylic acid - methyl methacrylate copolymer (1:1), corn starch, sucrose, polyethylene glycol 6000, propylene glycol, shellac, magnesium silicate, titanium dioxide, triethyl citrate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.